These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 4263829

  • 1. The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
    Papeschi R, Molina-Negro P, Sourkes TL, Erba G.
    Neurology; 1972 Nov; 22(11):1151-9. PubMed ID: 4263829
    [No Abstract] [Full Text] [Related]

  • 2. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
    Guilleminault C, Tharp BR, Cousin D.
    J Neurol Sci; 1973 Apr; 18(4):435-41. PubMed ID: 4540626
    [No Abstract] [Full Text] [Related]

  • 3. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA, Dowson JH, Ahmed R, Chow R, Gillingham FJ.
    Confin Neurol; 1972 Apr; 34(1):143-8. PubMed ID: 5084388
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA, Dowson JH, Ahmed R, Chow R, Gillingham FJ.
    Confin Neurol; 1972 Apr; 34(2):143-8. PubMed ID: 4666057
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.
    Barkhatova VP, Kandel' EI, Demina EG.
    Neurosci Behav Physiol; 1985 Apr; 15(2):132-9. PubMed ID: 3160969
    [No Abstract] [Full Text] [Related]

  • 10. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT, Ashcroft GW, Crawford TB, Eccleston D, Guldberg HC.
    Brain; 1970 Apr; 93(2):357-68. PubMed ID: 4912291
    [No Abstract] [Full Text] [Related]

  • 11. Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.
    Chase TN, Watanabe AM.
    Neurology; 1972 Apr; 22(4):384-92. PubMed ID: 5062828
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of L-dopa on monoamine metabolites in Parkinson's disease.
    van Woert MH, Bowers MB.
    Experientia; 1970 Apr; 26(2):161-3. PubMed ID: 5308739
    [No Abstract] [Full Text] [Related]

  • 16. On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.
    Casati C, Agnoli A, Jori A, Dolfini E.
    Z Neurol; 1973 Apr 02; 204(2):149-54. PubMed ID: 4121468
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H, Warter JM, Renaud B.
    Adv Neurol; 1984 Apr 02; 40():431-5. PubMed ID: 6198888
    [No Abstract] [Full Text] [Related]

  • 18. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
    Tabaddor K, Wolfson LI, Sharpless NS.
    Neurology; 1978 Dec 02; 28(12):1249-53. PubMed ID: 569783
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and pharmacologic studies of dystonia.
    Chase TN.
    Neurology; 1970 Nov 02; 20(11):122-30. PubMed ID: 5529474
    [No Abstract] [Full Text] [Related]

  • 20. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA, Wurtman RJ.
    N Engl J Med; 1975 Aug 14; 293(7):332-8. PubMed ID: 125386
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.